Merck launches New Pergoveris Pen for fertility treatment in India
A globally approved pen filled by mass technology provides a safer self- administration fertility solution
A globally approved pen filled by mass technology provides a safer self- administration fertility solution
A veteran in cell therapy and oncology commercialisation
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Board declares interim dividend of Rs 2 per equity share
All India Institute of Ayurveda hosts ministers and showcase their achievements
The company expects revenue growth of 10-15 per cent in the US
The transaction is expected to close in the Q4FY22
Advances deployment of mRNA technology across vaccines and therapeutics development
He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
Subscribe To Our Newsletter & Stay Updated